India’s pharmaceutical and cosmetic sector is on track to expand 2.2 to 2.4 times within the next six years, touching $120–130 billion, while its share of the global market is likely to reach five percent by 2030. These stats are expected to create demands for growing role of contract research and manufacturing services (CRAMS).
Additionally, while the market is shifting from a price-driven to value-driven one, and brands are looking for innovation, speed to market and uphold global competition, Ancalima Lifesciences Ltd stands resolute at this point.
Founded by Rajeev Garg, Ancalima Lifesciences is a well-established, pharmaceutical and cosmetic formulation company offering economy-friendly product, ranging from basic skincare and hair care items to more specialized pharmaceutical formulations.
With a Bachelor of Science (B.Sc)degree, and around 30 years of experience in the field of manufacturing and exports of pharmaceutical, veterinary and cosmetic formulations Rajeev Garg is a dynamic entrepreneur setting new standards of excellence and innovation, helping brands to grow in the market by becoming a trusted and perfect supporting partner.
The company specializes in manufacturing of pharmaceutical and cosmetic products by offering wide ranging products including injectables, eye/ear/nasal drops and external
applications (creams, ointments, gels, shampoos, lotions) and other pharmaceutical formulations for human healthcare to their global customers.
The company demonstrates its dedication to customer satisfaction, through a multi-faceted approach, adhering to international quality benchmarks like WHO-GMP and ISO, utilizing state-of-the-art facilities and offering end-to-end contract manufacturing solutions. Today, Ancalima Lifesciences is a key player in the pharmaceutical and cosmetic manufacturing industry, recognized for its quality and expertise, particularly in contract development and manufacturing (CDMO).
The biggest challenge faced by this industry is the rising competition with the emergence of new players. They need to understand strict regulations and compliance, R&D costs and innovation. With over three decades of experience in maintaining global compliance, and a robust R&D team and expert system in place Ancalima Lifesciences expertly overcomes such challenges.
The company emphasizes innovation and R&D, with dedicated team assisting new brands with trademark registration, custom formulations and process optimization. Its facilities are equipped to handle diverse batch sizes, from pilot-scale to large commercial volumes, across various product types. Also, it has the state-of-the-art facilities designed to conduct testing and verification of its products.
Ancalima Lifesciences believes in the philosophy of trust, transparency and consistency, batch after batch
Growth & Future Roadmap
In 1994, Ancalima Lifesciences began with pharmaceutical manufacturing like injectables, eye drops and ointments and has steadily evolved into cosmetics formulation as well. While its huge R&D team is helping in developing new products, the company is also exploring the idea of offering serums in ampoule or vial form as single-dose presentations. This format is already accepted in international markets, and some products in India also use it, and are studying the possibilities and working on such options.
Rajeev Garg, Managing Director (Pharma & Cosmetic Formulations), Ancalima Lifesciences says, “Currently, we export to 10 countries, however we are planning to extend our footprint to 20–30 more. At the same time, we aspire to positioning ourselves as a reliable and sustainable cosmetic contract manufacturer for diverse brands. At Ancalima Lifesciences, we believe in the philosophy of trust, transparency and consistency, batch after batch”.
We use cookies to ensure you get the best experience on our website. Read more...